HCA Healthcare EPS - Earnings per Share 2012-2025 | HCA
HCA Healthcare annual and quarterly earnings per share history from 2012 to 2025. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- HCA Healthcare EPS for the quarter ending December 31, 2025 was $8.09, a 42.93% increase year-over-year.
- HCA Healthcare EPS for the twelve months ending December 31, 2025 was $28.33, a 28.77% increase year-over-year.
- HCA Healthcare 2025 annual EPS was $28.33, a 28.77% increase from 2024.
- HCA Healthcare 2024 annual EPS was $22, a 15.97% increase from 2023.
- HCA Healthcare 2023 annual EPS was $18.97, a 0.94% decline from 2022.
| HCA Healthcare Annual EPS | |
|---|---|
| 2025 | $28.33 |
| 2024 | $22.00 |
| 2023 | $18.97 |
| 2022 | $19.15 |
| 2021 | $21.16 |
| 2020 | $10.93 |
| 2019 | $10.07 |
| 2018 | $10.66 |
| 2017 | $5.95 |
| 2016 | $7.30 |
| 2015 | $4.99 |
| 2014 | $4.16 |
| 2013 | $3.37 |
| 2012 | $3.49 |
| 2011 | $4.97 |
| HCA Healthcare Quarterly EPS | |
|---|---|
| 2025-12-31 | $8.09 |
| 2025-09-30 | $6.96 |
| 2025-06-30 | $6.83 |
| 2025-03-31 | $6.45 |
| 2024-12-31 | $5.66 |
| 2024-09-30 | $4.88 |
| 2024-06-30 | $5.53 |
| 2024-03-31 | $5.93 |
| 2023-12-31 | $5.92 |
| 2023-09-30 | $3.91 |
| 2023-06-30 | $4.29 |
| 2023-03-31 | $4.85 |
| 2022-12-31 | $7.20 |
| 2022-09-30 | $3.91 |
| 2022-06-30 | $3.90 |
| 2022-03-31 | $4.14 |
| 2021-12-31 | $5.66 |
| 2021-09-30 | $7.00 |
| 2021-06-30 | $4.36 |
| 2021-03-31 | $4.14 |
| 2020-12-31 | $4.13 |
| 2020-09-30 | $1.95 |
| 2020-06-30 | $3.16 |
| 2020-03-31 | $1.69 |
| 2019-12-31 | $3.09 |
| 2019-09-30 | $1.76 |
| 2019-06-30 | $2.25 |
| 2019-03-31 | $2.97 |
| 2018-12-31 | $3.02 |
| 2018-09-30 | $2.15 |
| 2018-06-30 | $2.31 |
| 2018-03-31 | $3.18 |
| 2017-12-31 | $1.31 |
| 2017-09-30 | $1.15 |
| 2017-06-30 | $1.75 |
| 2017-03-31 | $1.74 |
| 2016-12-31 | $2.37 |
| 2016-09-30 | $1.59 |
| 2016-06-30 | $1.65 |
| 2016-03-31 | $1.69 |
| 2015-12-31 | $1.40 |
| 2015-09-30 | $1.05 |
| 2015-06-30 | $1.18 |
| 2015-03-31 | $1.36 |
| 2014-12-31 | $1.17 |
| 2014-09-30 | $1.16 |
| 2014-06-30 | $1.07 |
| 2014-03-31 | $0.76 |
| 2013-12-31 | $0.93 |
| 2013-09-30 | $0.79 |
| 2013-06-30 | $0.91 |
| 2013-03-31 | $0.74 |
| 2012-12-31 | $0.68 |
| 2012-09-30 | $0.78 |
| 2012-06-30 | $0.85 |
| 2012-03-31 | $1.18 |
| 2011-12-31 | $3.91 |
| 2011-09-30 | $0.11 |
| 2011-06-30 | $0.43 |
| 2011-03-31 | $0.52 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $120.821B | $75.600B |
| HCA Healthcare Inc. is a provider of healthcare services comprising hospitals and ambulatory sites of care including surgery centers, freestanding ERs, urgent care centers and physician clinics. HCA Healthcare Inc., formerly known as HCA HOLDINGS, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $150.156B | 27.25 |
| CVS Health (CVS) | United States | $99.843B | 11.63 |
| Elevance Health (ELV) | United States | $76.540B | 11.49 |
| Cencora (COR) | United States | $70.193B | 22.08 |
| Natera (NTRA) | United States | $28.526B | 0.00 |
| Labcorp Holdings (LH) | United States | $23.430B | 17.86 |
| DiDi Global (DIDIY) | China | $21.650B | 20.00 |
| Viatris (VTRS) | United States | $18.163B | 6.77 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.306B | 0.00 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| Solventum (SOLV) | United States | $13.104B | 12.72 |
| Medpace Holdings (MEDP) | United States | $12.148B | 27.98 |
| Revvity (RVTY) | United States | $10.887B | 18.94 |
| CochLear (CHEOY) | Australia | $9.243B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.941B | 15.29 |
| ICON (ICLR) | Ireland | $7.510B | 7.45 |
| Sonic Healthcare (SKHHY) | Australia | $7.449B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.008B | 41.78 |
| HealthEquity (HQY) | United States | $6.312B | 23.60 |
| Avantor (AVTR) | United States | $6.275B | 10.11 |
| Bausch + Lomb (BLCO) | Canada | $6.034B | 39.60 |
| PACS (PACS) | United States | $5.922B | 36.01 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.818B | 0.00 |
| Sotera Health (SHC) | United States | $4.864B | 23.45 |
| Alignment Healthcare (ALHC) | United States | $4.040B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.017B | 18.83 |
| GeneDx Holdings (WGS) | United States | $2.606B | 45.76 |
| Establishment Labs Holdings (ESTA) | United States | $2.168B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.000B | 25.77 |
| Organon (OGN) | United States | $1.921B | 2.15 |
| Pediatrix Medical (MD) | United States | $1.848B | 11.04 |
| Progyny (PGNY) | United States | $1.784B | 35.07 |
| Ardent Health (ARDT) | United States | $1.375B | 4.49 |
| InnovAge Holding (INNV) | United States | $1.134B | 167.20 |
| CareDx (CDNA) | United States | $1.010B | 16.50 |
| Teladoc Health (TDOC) | United States | $0.825B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.740B | 12.11 |
| Nutex Health (NUTX) | United States | $0.705B | 5.39 |
| Omada Health (OMDA) | United States | $0.655B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.641B | 0.00 |
| Embecta (EMBC) | United States | $0.602B | 3.36 |
| Enhabit (EHAB) | United States | $0.565B | 25.36 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.558B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.478B | 8.79 |
| CryoPort (CYRX) | United States | $0.418B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.396B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.367B | 5.90 |
| So-Young (SY) | China | $0.328B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.269B | 0.00 |
| Oncology Institute (TOI) | United States | $0.247B | 0.00 |
| Agilon Health (AGL) | United States | $0.150B | 0.00 |
| LifeMD (LFMD) | United States | $0.134B | 0.00 |
| Beauty Health (SKIN) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.078B | 0.00 |
| DocGo (DCGO) | United States | $0.073B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.039B | 0.00 |
| Pomdoctor - (POM) | China | $0.026B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.018B | 5.62 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |